Mark W. Begor - 10 Feb 2023 Form 4 Insider Report for EQUIFAX INC (EFX)

Role
CEO, Director
Signature
/s/Lisa Stockard as Attorney-in-Fact
Issuer symbol
EFX
Transactions as of
10 Feb 2023
Net transactions value
$0
Form type
4
Filing time
14 Feb 2023, 15:13:31 UTC
Previous filing
05 Jan 2023
Next filing
23 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFX Common Stock Award $0 +9,799 +14% $0.000000 77,831 10 Feb 2023 Direct F1, F2
holding EFX Common Stock 20,382 10 Feb 2023 2-Year 2021 GRAT
holding EFX Common Stock 40,000 10 Feb 2023 2-Year 2022 GRAT
holding EFX Common Stock 25,000 10 Feb 2023 2-year May 2022 GRAT
holding EFX Common Stock 35,383 10 Feb 2023 4-Year 2021 GRAT

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFX Stock Option/Right to Buy Award $0 +18,346 $0.000000 18,346 10 Feb 2023 Common Stock 18,346 $247.39 Direct F3
transaction EFX Stock Option/Right to Buy Award $0 +16,580 $0.000000 16,580 10 Feb 2023 Common Stock 16,580 $226.78 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2026.
F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3 Annual equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on February 10, 2026.